Dr. Bernstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 Lakeville Road
Suite 311
New Hyde Park, NY 11042Phone+1 516-838-6415Fax+1 516-465-5226
Education & Training
- Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 1982 - 1985
- Rowan University School of Osteopathic MedicineClass of 1982
Certifications & Licensure
- NJ State License 1983 - Present
- NY State License 2010 - 2026
- MA State License 1995 - 2024
- NH State License 2005 - 2019
- PA State License 1983 - 1996
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
Publications & Presentations
PubMed
- 585 citationsUpdated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus InfectionMichael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary Anne Jackson
Pediatrics. 2014-08-01 - 116 citationsImmune responses in infants whose mothers received Tdap vaccine during pregnancy.Abbey J Hardy-Fairbanks, Stephanie J. Pan, Michael D. Decker, David R. Johnson, David P. Greenberg
The Pediatric Infectious Disease Journal. 2013-11-01 - 231 citationsPolicy statement - Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infectionsJoseph A. Bocchini, Henry H. Bernstein, John S. Bradley, Michael T. Brady, Carrie L. Byington
Pediatrics. 2009-12-01
Press Mentions
- FDA Advisors Vote in Favor of Pfizer’s RSV Vaccine to Protect InfantsMay 18th, 2023
- FDA Panel Backs Second RSV Vaccine for Older AmericansMarch 2nd, 2023
- FDA Panel Backs Second RSV Vaccine for Older AmericansMarch 2nd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: